Financhill
Buy
63

PHAR Quote, Financials, Valuation and Earnings

Last price:
$10.18
Seasonality move :
-10.82%
Day range:
$9.90 - $10.23
52-week range:
$6.65 - $11.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.72x
P/B ratio:
3.10x
Volume:
2.4K
Avg. volume:
4.2K
1-year change:
3.53%
Market cap:
$686M
Revenue:
$297.2M
EPS (TTM):
-$0.16

Earnings Data

Next earnings date for PHAR
Jul 31
2025
Most recent earnings per share
$0.04
Beat by $0.03
(Mar 13/2025)
Consensus Estimate
$0.01
(Mar 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q2 $82.2M -- -- -$0.01 --
05/08/2025 Q1 $64.1M -- -- -$0.03 --
03/13/2025 Q4 $80.6M $92.7M $0.04 $0.01 $0.03
10/24/2024 Q3 $76M $74.8M -$0.02 -$0.00 -$0.02
08/01/2024 Q2 $72M $74.1M -$0.01 -$0.00 -$0.01
05/08/2024 Q1 $69.9M $55.6M -$0.19 $0.01 -$0.20
03/14/2024 Q4 -- $81.2M -$0.05 $0.00 -$0.05
10/26/2023 Q3 $61.7M $66.7M $0.05 -$0.01 $0.06
08/03/2023 Q2 $54.3M $54.9M $0.02 -$0.02 $0.04
05/11/2023 Q1 $48.3M $42.5M -$0.19 -- --
03/16/2023 Q4 -- $54.6M -$0.22 -- --
10/27/2022 Q3 -- $54.2M $0.13 -- --
08/04/2022 Q2 -- $50.1M $0.22 -- --
05/12/2022 Q1 -- $46.6M $0.05 -- --
03/17/2022 Q4 -- $52.8M $0.03 -- --
10/28/2021 Q3 -- $52.9M -$0.01 -- --
08/05/2021 Q2 -- $49.7M $0.06 -- --
05/13/2021 Q1 -- $43.6M $0.13 -- --
03/04/2021 Q4 -- $54M $0.11 -- --
09/30/2020 Q3 -- $58.5M $0.13 -- --
06/30/2020 Q2 -- $45.3M $0.16 -- --
03/31/2020 Q1 -- $54.4M $0.12 -- --
12/31/2019 Q4 -- $54.4M $0.22 -- --
09/30/2019 Q3 -- $46.4M $0.17 -- --
06/30/2019 Q2 -- $49.1M $0.12 -- --
03/31/2019 Q1 -- $39.6M $0.11 -- --
12/31/2018 Q4 -- $40.4M $0.19 -- --
09/30/2018 Q3 -- $45.5M $0.09 -- --
06/30/2018 Q2 -- $32.4M $0.05 -- --
03/31/2018 Q1 -- $36.3M $0.10 -- --
12/31/2017 Q4 -- $40.9M -$0.92 -- --
09/30/2017 Q3 -- $31.6M -$0.20 -- --
06/30/2017 Q2 -- $18.5M -$0.60 -- --
03/31/2017 Q1 -- $16.5M -$0.13 -- --
12/31/2016 Q4 -- $6.9M -$0.16 -- --
09/30/2016 Q3 -- $3.9M -$0.10 -- --
06/30/2016 Q2 -- $3.4M -$0.09 -- --
03/31/2016 Q1 -- $2.5M -$0.09 -- --
12/31/2015 Q4 -- $2.3M -$0.11 -- --
09/30/2015 Q3 -- $3.7M -$0.07 -- --
06/30/2015 Q2 -- $3.9M -$0.07 -- --

Pharming Group Earnings Questions

  • How Much did Pharming Group Generate in Revenue Last Quarter?

    Pharming Group reported $92.7M worth of top line sales in its most recent quarter.

  • Did Pharming Group Beat Earnings Last Quarter?

    Pharming Group announced earnings per share of $0.04 which represents a beat of analyst forecast a $0.01 per share.

  • Is Pharming Group Profitable?

    Pharming Group reported $80.5M that represents $1.08 per share over the last quarter.

  • What is the Analyst Consensus for Pharming Group EPS Next Year?

    Pharming Group's earnings are forecast to decrease from -$0.18 per share to -$0.01 per share next year representing a decrease of -82.22%.

  • When is Pharming Group's Earnings Date?

    Pharming Group's next earnings date is July 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock